06.11.2013 • NewsArtenius Turkpetethylene oxideLa Seda

La Seda Asset Sale Now in Progress

The disposal of assets belonging to insolvent Spanish PET producer has been approved by the Barcelona commercial court handling the proceedings. Authorities have now given the green light for liquidation of Artenius Espana at Barcelona; Industrias Químicas Asociadas (IQA) at Tarragona; Artenius Italia in San Giorgio di Nogaro, near Udine, Italy; and Artenius Turkpet in Adana, Turkey. The divestment process for PET recycler Artenius Green in Balaguer, Spain, is expected to begin shortly.

Artenius Espana has nameplate capability for 170,000 t/y of PET, while IQA produces PET starting materials ethylene oxide (EO) and monoethylene glycol (MEG). Turkpet produces 140,000 t/y of PET. Reports from Italy suggest that four potential buyers have been lined up for the Italian plant with a capacity for 100,000 t/y of PET.  

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.